Psoriasis – Friday Pop Quiz 02/05
123001230012300
What is the most likely diagnosis in this 16-year-old patient who developed this generalized eruption two weeks after onset of a sore throat due to strep infection?
A. Psoriasis
B. Pityriasis rosea
C. Cutaneous T-cell lymphoma
D. Contact dermatitis
E. Lichen planus
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner D …
What is the most likely diagnosis in this 16-year-old patient who developed this generalized eruption two weeks after onset of a sore throat due to strep infection?
A. Psoriasis
B. Pityriasis rosea
C. Cutaneous T-cell lymphoma
D. Contact dermatitis
E. Lichen planus
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner D … 
The February issue of the Journal of Drugs in Dermatology features an outstanding line-up of articles with topics ranging from acne and depression to "Inflammaging. Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Efforts are needed to implement a clinically useful definition of moderate plaque psoriasis in Dermatologists’ Perspectives on Defining Moderate Ps … 
The December issue of the Journal of Drugs in Dermatology focuses on a variety of topics ranging from plaque psoriasis and infantile hemangioma to suturing wounds under tension and cannabinoid gel on sensitive dry skin. And an incredible line-up of articles to finish 2020 strong! Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Oxytocin Levels Inversely Correla … 
Partnering Medical Therapies and Procedural Interventions to Treat the Whole Patient
Over the last decade, tremendous advances have revolutionized the treatment of chronic inflammatory skin conditions such as atopic dermatitis and psoriasis. These dermatological victories have shed light on skin diseases that need more attention. Hidradenitis suppurativa (HS), which disproportionately affects pat … 
When standard treatment options fail and corticosteroids are not a long-term option, dermatologists often have to look back to their tool-kit and pull out the “big guns.” Mycophenolate mofetil has emerged as a promising immunosuppressive agent for severe immune-mediated and inflammatory dermatologic disease. We continue our series, Therapeutic Cheat Sheet, with a closer look at mycophenolate m … 